Epilepsy drugs and effects on fetal development: Potential mechanisms

Journal of Research in Medical Sciences

Volumn 17, Issue 9, 2012, Pages 876-881

  Etemad, Leila ^a   Moshiri, Mohammad ^a   Moallem, Seyed Adel ^a,b,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti epileptic drugs; Epilepsy; Pregnancy; Teratogen

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; EPOXIDE; EPOXIDE HYDROLASE; ETIRACETAM; FOLIC ACID; GABAPENTIN; HOMOCYSTEINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; TRIMETHADIONE; VALPROIC ACID; VIGABATRIN;

APOPTOSIS; ARTICLE; CLEFT FACE; CLEFT LIP PALATE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; EPILEPSY; FETAL HYDANTOIN SYNDROME; FETUS DEVELOPMENT; FOLIC ACID DEFICIENCY; GENETIC SUSCEPTIBILITY; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPOSPADIAS; HYPOXIA; LIMB DEFECT; MICROCEPHALY; MOUTH DISEASE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY; REOXYGENATION; RISK; SIDE EFFECT; SPINAL DYSRAPHISM; TERATOGENICITY;

EID: 84869443996     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Perucca E. Birth defects after prenatal exposure to antiepileptic drugs. Lancet Neurolo 2005;4:781-6.
2. Barrett C, Richens A. Epilepsy and pregnancy: Report of an epilepsy research foundation workshop. Epilepsy Res 2003;52:147-87.
3. Minkoff H, Schaffer RM, Delke I, Grunebaum AN. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol 1985;65(3 Suppl):22S-4S.
4. Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LI. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978;7:241-7.
5. Jick SS, Terris BZ. Anticonvulsants and congenital malformations. Pharmacotherapy 1997;17:561-4.
6. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F. Anticonvulsants, folate levels, and pregnancy outcome: A prospective study. Ann Neurol 1987;21:176-182.
7. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, WaddellR, et al., Malformation risks of antiepileptic drugs in pregnancy: A prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8.
8. Battino D, Tomson T. Management of epilepsy during pregnancy. Drugs 2007;67:2727-46.
9. Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy:Independent effects of epilepsy and medications. Am J Med Genet 1997;68:18-24.
10. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM et al., The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-8.
11. Fedrick J. Epilepsy and pregnancy: A report from the Oxford record linkage study Br. Med. J. 1973;2:442-8.
12. Thomas SV, Indrani L, Devi GC, Jacob S, Beegum J, Jacob PP, et al., Pregnancy in women with epilepsy: Preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India 2001;49:60-6.
13. Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet 1968;2:1296.
14. Palmieri C, Canger R. Teratogenic potential of the newer antiepileptic drugs. CNS Drugs 2002;16:755-64.
15. Friis ML, Kristensen O, Boas J, Dalby M, Deth SH, Gram L, et al. Therapeutic experiences with 947 epileptic outpatients in oxcarbezepine treatment. Acta Neurol Scand 1993;87:224-7.
16. Hanson JW. Teratogen update: Fetal hydantoin effects. Teratology 1986;33:349-53.
17. Finnell RH, Chernoff GF. Mouse fetal hydantoin syndrome: Effects of maternal seizures. Epilepsia 1982;23:423-9.
18. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-46.
19. Stoll C, Audeoud F, Gaugler C, Bernardin A, Messer J. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero. Genet Couns 2003;14:289-98.
20. Vajda FJ, O'Brien TJ, Hitchcock A, Graham J, Cook M, Landerc C, et al., Critical relationship between sodium valproate dose and human teratogenicity: Results of the Australian register of anti-epileptic drugs in pregnancy J Clin Neurosci 2004;11:854-8.
21. Afshar M, Moallem SA, Houshang Mohammadpour A, ShiraviA, Majid Jalalian S, Jafar Golalipour M. Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice. Cutan Ocul Toxicol 2010;29:10-15.
22. Afshar M, Moallem SA, Jalilian M, Shiravi A. Novel teratogenic effects of carbamazepine on fetal development in mice by intraperitoneal injection. in The Asian-Pacific International Congress of Anatomists. Tehran, Iran: 8th Iranian Congress of Anatomical Sciences; 2008.
23. Buehler BA. Epoxide hydrolase activity in fibroblasts:correlation with clinical features of the fetal hydantoin syndrome. Proc Greenwood Genet Cent 1987;6:117.
24. Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, WongSL, et al., Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008;70(22 Pt 2):2152-8.
25. Cunnington M, Tennis P. International Lamotrigine Pregnancy Registry Scientific Advisory Committee: Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-60.
26. Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 2011;76:1817-23.
27. Vajda FJ, Graham J, Roten A, Lander CM, O'Brien TJ, Eadie M. Teratogenicity of the newer antiepileptic drugs-the Australian experience. J Clin Neurosci 2011;19:57-9.
28. Montouris G. Safety of the newer antiepileptic drug oxcarbazepine during pregnancy. Curr Med Res Opin 2005;21:693-701.
29. Afshar M, Hassanzadeh-Taheri MM, Moallem SA, Tamizi A, Golalipour MJ. Teratogenic effects of gabapentin on the skeletal system of Balb/C mice fetuses. Neurosciences (Riyadh) 2009;14:239-44.
30. Afshar M, Hasanzadeh MM, Moallem SA, Tamizi A, Golalipour Jomparative study of teratogenic effects of oral and intraperitoneal administrations of gabapentin on the skeletal system of Balb/c mice. J Iran U Med Sci 2010;16:7-18.
31. Montouris G. Gabapentin exposure in human pregnancy: Results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003;4:310-7.
32. Ornoy A, Zvi N, Arnon J, Wajnberg R, Shechtman S, Diav-Citrin O. The outcome of pregnancy following topiramate treatment: A study on 52 pregnancies. Reprod Toxicol 2008;25;388-9
33. Hunt S, Craig J, Russell A, Guthrie E, Parsons L, Robertson I, et al., Levetiracetam in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006;67:1876-9.
34. Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, et al., Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008;71;272-6.
35. Battino D, Kaneko S, Andermann E, Avanzini G, CaneviniMP, Canger R, et al., Intrauterine growth in the offspring of epileptic women: A prospective multicenter study. Epilepsy Res 1999;36:53-60.
36. Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, et al., Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-58.
37. Lindhout D, Meinardi H, Barth PG. Hazards of foetal exposure to drug combinations, in Epilepsy, Pregnancy, and the Child. In: Janz D, Bossi L, Dam M, Helge H, Richens A, Schmidt D, editors. New York: Raven Press; 1982. p. 275-81.
38. Ramsay RE, Slater JD. Effects of antiepileptic drugs on hormones. Epilepsia 1991;32 (Suppl 6) S60-7.
39. th days of pregnancy. Teratology Conference, Cincinnati, Ohio, USA, 1961;18.
40. Hansen DK, Billings RE. Phenytoin teratogenicity and effects on embryonic and maternal folate metabolism[published errtum appears in Teratology 1986 Dec;34(3):487]. Teratology 1985;31:363-71.
41. rd, Blake DA. Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharm Exp Ther 1977;203:231-9.
42. Lindhout D, Hoppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77-83.
43. Harbison RD, Becker BA. Effects of phenobarbital or SKF 525 A pretreatment on diphenylhydantoin disposition in pregnant mice. Toxicol Appl Pharmacol 1971;20;573-81.
44. Lavoie A, Tripp E, Parsa K, Hoffbrand AV. Polyglutamate forms of folate in resting and proliferating mammalian tissues. Clin Sci Mol Med 1975;48;67-73.
45. Jhaveri MS, Wagner C, Trepel JB. Impact of extracellular folate levels on global gene expression. Mol Pharmacol 2001;60:1288-95.
46. Afshar M, Moallem SA, Baharara J, Takjo T. The protective role of folic acidon tratogenic effect of Carbamazepine in Balb/c mice. J Gorgan U Med Sci 2010;12:1-9.
47. Zhu MX, Zhou SS, Reduction of the teratogenic effects of phenytoin by folic acid and a mixture of folic acid, vitamins, and amino acids: A preliminary trial. Epilepsia 1989;30:246-51.
48. Trotza M, Wegnera C, Nau H. Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse Life Sciences 1987;41:103-10.
49. Biale Y, Lewenthal H. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 1984;18:211-6.
50. Schardein JL, Dresner AJ, Hentz DL, Petrere JA, Fitzgerald JE, Kurtz SM. The modifying effect of folinic acid on diphenylhydantoin-induced teratogenicity in mice. Toxicol Appl Pharmacol 1973;24;150-8.
51. Sullivan FM, McElhatton PR. Teratogenic activity of the antiepileptic drugs phenobarbital, phenytoin, and primidone in mice. Toxicol Appl Pharmacol 1975;34:271-82.
52. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000;343:1608-14.
53. Gos MJ, Szpecht-Potocka A. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism. J Appl Genet 2002;43:511-24.
54. Azarbayjani F, Danielsson BR. Embryonic arrhythmia by inhibition of HERG channels: A common hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia 2002;43:457-68.
55. Fantel AG, Barber CV, Carda MB, Tumbic RW, Mackler B. Studies of the role of ischemia/reperfusion and superoxide anion radical production in the teratogenicity of cocaine. Teratology 1992;46:293-300.
56. Danielsson BR, Danielson M, Rundqvist E, Reiland S. Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity. Teratology 1992;45:247-58.
57. Danielsson BR, Danielsson C, Nilsson MF. Embryonic cardiac arrhythmia and generation of reactive oxygen species: Common teratogenic mechanism for IKr blocking drugs. Reprod Toxicol 2007;24:42-56.
58. Moallem SA, Hales BF. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development 1998;125:3225-34.
59. Moallem SA, Hales BF. Induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of cyclophosphamide. Teratology 1995;52:3-14.
60. Scott WJ. Cell death and reduced proliferative rate. In: WilsonJG, Fraser F, editors. Handbook of Teratology. New York/London: Plenum Press; 1997. p. 81-98.
61. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al., Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002;99:15089-94.
62. Meador KJ. Effects of in utero antiepileptic drug exposure. Epilepsy Curr 2008;8:143-7.
63. Buhimschi CS, Weiner CP, Medications in pregnancy and lactation: Part 1. Teratology. Obstet Gynecol 2009;113:166-88.
64. Hansen DK, Hodes ME. Metabolism of phenytoin in teratogenesissusceptible and-resistant strains of mice. Drug Metab Dispos 1983;11:21-4.
65. Dean JC, Moore SJ, Osborne A, Howe J, Turnpenny PD. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet 1999;56:216-20.
66. Tung EW, Winn LM. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: A role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol 2011;80:979-87.
67. Jergil M, Forsberg M, Salter H, Stockling K, Gustafson AL, Dencker L, et al., Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells. Toxicol Sci 2011;121:328-42.
68. Jergil M, Kultima K, Gustafson AL, Dencker L, Stigson M. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. Toxicol Sci 2009;108:132-48.
69. Landmark CJ, Johannessen SI. Safety aspects of antiepileptic drugs--focus on pharmacovigilance. Pharmacoepidemiol Drug Saf 2011;21:11-20.
70. Forcelli PA, Janssen MJ, Vicini S, Gale K. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol 2012. doi: 10.1002/ana.23600. [Epub ahead of print]
71. Tremolizzo L, Difrancesco JC, Rodriguez-Menendez V, RivaC, Conti E, Galimberti G, et al., Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients. Prog Neuropsychopharmacol Biol Psychiatry 2012;39:47-51.